Brief: Calliditas Files For Full Marketing Authorization Of Kinpeygo® In EU
28/09/2023 11:06
Sept 28 (Reuters) - Calliditas Therapeutics AB
CALTX.ST :
* STADA AND CALLIDITAS ANNOUNCE THE FILING FOR FULL
MARKETING
AUTHORIZATION OF KINPEYGO® IN THE EU
Source text for Eikon: ID:nWkr2Xcv5g
Further company coverage: CALTX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Calliditas Therapeutics AB
See all newsBrief: Calliditas To Be Delisted From Nasdaq Stockholm
Brief: Calliditas Therapeutics Takes Certain Corporate Actions Following Announcement By Asahi Kasei
Brief: Asahi Kasei Corp: Notice Regarding Results Of Tender Offer For Shares Of Calliditas Therapeutics AB And Transfer Of Subsidiary
Calliditas Therapeutics AB reports results for the quarter ended in January - Earnings Summary
Brief: Calliditas Q2 Sales Beat Expectations